Key facts
- It has raised $1.6M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Innovate UK, Tech Nation Group, EIT Food, Big Idea Ventures, Chemstars — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for New Wave Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for New Wave Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About New Wave Biotech
Developer of a bioprocess engineering platform designed to optimize the development of synthetic biology products. The company's platform utilizes virtual experimentation and techno-economic analysis to identify key levers for improvement in yield, cost, quality and sustainability, enabling healthcare companies to get their products to market at a lower cost.
- Sector
- Healthcare
- HQ
- Manchester, United Kingdom
- Founded
- 2022
- Employees
- 10
- Website
- newwavebiotech.com/
- Ownership
- Privately Held (backing)
New Wave Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in New Wave Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on New Wave Biotech in its N-PORT filings yet. We sweep new filings monthly.